학술논문
Discovery of vimseltinib (DCC-3014), a highly selective CSF1R switch-control kinase inhibitor, in clinical development for the treatment of Tenosynovial Giant Cell Tumor (TGCT)
Document Type
Article
Author
Source
In: Bioorganic and Medicinal Chemistry Letters . (Bioorganic and Medicinal Chemistry Letters, 15 October 2022, 74)
Subject
Language
English
ISSN
14643405
0960894X
0960894X